409 related articles for article (PubMed ID: 31282420)
1. Vascular and Neurodegenerative Markers for the Prediction of Post-Stroke Cognitive Impairment: Results from the TABASCO Study.
Molad J; Hallevi H; Korczyn AD; Kliper E; Auriel E; Bornstein NM; Ben Assayag E
J Alzheimers Dis; 2019; 70(3):889-898. PubMed ID: 31282420
[TBL] [Abstract][Full Text] [Related]
2. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts.
Weaver NA; Kuijf HJ; Aben HP; Abrigo J; Bae HJ; Barbay M; Best JG; Bordet R; Chappell FM; Chen CPLH; Dondaine T; van der Giessen RS; Godefroy O; Gyanwali B; Hamilton OKL; Hilal S; Huenges Wajer IMC; Kang Y; Kappelle LJ; Kim BJ; Köhler S; de Kort PLM; Koudstaal PJ; Kuchcinski G; Lam BYK; Lee BC; Lee KJ; Lim JS; Lopes R; Makin SDJ; Mendyk AM; Mok VCT; Oh MS; van Oostenbrugge RJ; Roussel M; Shi L; Staals J; Del C Valdés-Hernández M; Venketasubramanian N; Verhey FRJ; Wardlaw JM; Werring DJ; Xin X; Yu KH; van Zandvoort MJE; Zhao L; Biesbroek JM; Biessels GJ
Lancet Neurol; 2021 Jun; 20(6):448-459. PubMed ID: 33901427
[TBL] [Abstract][Full Text] [Related]
3. Atrial Fibrillation is Independently Associated with Cognitive Impairment after Ischemic Stroke.
Chander RJ; Lim L; Handa S; Hiu S; Choong A; Lin X; Singh R; Oh D; Kandiah N
J Alzheimers Dis; 2017; 60(3):867-875. PubMed ID: 28922154
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score.
Kandiah N; Chander RJ; Lin X; Ng A; Poh YY; Cheong CY; Cenina AR; Assam PN
J Alzheimers Dis; 2016; 49(4):1169-77. PubMed ID: 26599056
[TBL] [Abstract][Full Text] [Related]
5. Serum Retinoic Acid Level and The Risk of Poststroke Cognitive Impairment in Ischemic Stroke Patients.
Hou L; Ding C; Chen Z; Liu Y; Shi H; Zou C; Zhang H; Lu Z; Zheng D
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104352. PubMed ID: 31501037
[TBL] [Abstract][Full Text] [Related]
6. Association Between Small Vessel Disease Markers, Medial Temporal Lobe Atrophy and Cognitive Impairment After Stroke: A Systematic Review and Meta-Analysis.
Wang F; Hua S; Zhang Y; Yu H; Zhang Z; Zhu J; Liu R; Jiang Z
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105460. PubMed ID: 33227579
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Cognitive Impairment After Stroke: A Prospective Stroke Cohort Study.
Ding MY; Xu Y; Wang YZ; Li PX; Mao YT; Yu JT; Cui M; Dong Q
J Alzheimers Dis; 2019; 71(4):1139-1151. PubMed ID: 31524163
[TBL] [Abstract][Full Text] [Related]
8. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
Ben Assayag E; Eldor R; Korczyn AD; Kliper E; Shenhar-Tsarfaty S; Tene O; Molad J; Shapira I; Berliner S; Volfson V; Shopin L; Strauss Y; Hallevi H; Bornstein NM; Auriel E
Stroke; 2017 Sep; 48(9):2368-2374. PubMed ID: 28801477
[TBL] [Abstract][Full Text] [Related]
9. Poststroke Cognitive Impairment: A Longitudinal Follow-Up and Pre/Poststroke Mini-Mental State Examination Comparison.
Hong CT; Lee HH; Chung CC; Chiu WT; Lee TY; Chen DY; Huang LK; Hu CJ; Chan L
Curr Alzheimer Res; 2022; 19(10):716-723. PubMed ID: 35927922
[TBL] [Abstract][Full Text] [Related]
10. China Alzheimer's Disease and Neurodegenerative Disorder Research (CANDOR) -A Prospective Cohort Study for Alzheimer's Disease and Vascular Cognitive Impairment.
Li S; Dong H; Wang Y; Wang S; Lv X; Dong M; Tian S; Shi J
J Prev Alzheimers Dis; 2024; 11(1):214-221. PubMed ID: 38230734
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke.
Chander RJ; Lam BYK; Lin X; Ng AYT; Wong APL; Mok VCT; Kandiah N
Sci Rep; 2017 Sep; 7(1):12441. PubMed ID: 28963553
[TBL] [Abstract][Full Text] [Related]
13. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
Scott TM; Bhadelia RA; Qiu WQ; Folstein MF; Rosenberg IH
J Alzheimers Dis; 2018; 65(1):293-302. PubMed ID: 30040728
[TBL] [Abstract][Full Text] [Related]
14. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
15. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study.
Debette S; Beiser A; DeCarli C; Au R; Himali JJ; Kelly-Hayes M; Romero JR; Kase CS; Wolf PA; Seshadri S
Stroke; 2010 Apr; 41(4):600-6. PubMed ID: 20167919
[TBL] [Abstract][Full Text] [Related]
16. Effects of glycemic variability and hyperglycemia in acute ischemic stroke on post-stroke cognitive impairments.
Lim JS; Kim C; Oh MS; Lee JH; Jung S; Jang MU; Lee SH; Kim YJ; Kim Y; Suh SW; Lee BC; Yu KH
J Diabetes Complications; 2018 Jul; 32(7):682-687. PubMed ID: 29793824
[TBL] [Abstract][Full Text] [Related]
17. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
Dickie DA; Quinn TJ; Dawson J
Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
[TBL] [Abstract][Full Text] [Related]
19. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
20. Plasma parameters and risk factors of patients with post-stroke cognitive impairment.
Wu JX; Xue J; Zhuang L; Liu CF
Ann Palliat Med; 2020 Jan; 9(1):45-52. PubMed ID: 32005062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
